GL1X · GenesisL1 explorer

Research workbench

An antidote for dabigatran

Analyse An antidote for dabigatran in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4JN2
Type
protein
Length
877 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti dabigatran Fab
Ligands
4CC
Pockets
11 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, LAnti dabigatran Fabprotein2196% helix, 50% strand—
BAnti dabigatran Fabprotein2147% helix, 52% strand—
HAnti dabigatran Fabprotein2258% helix, 52% strand—

Ligands and binding sites

  • 4CC · N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine · ligand · 2 copies · chains A, B, H, L
  • GOL · Glycerol · additive · 8 copies · chains A, B, H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17910.680.7586empty
27800.670.7569GOL
3560.530.8922empty
41990.530.7735empty
52280.510.7624empty

Interfaces

3 interfaces between chains.

  • H–L · 2012 Ų buried · 18 hydrogen bonds · protein-protein
  • A–B · 1849 Ų buried · 18 hydrogen bonds · protein-protein
  • A–L · 533 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 4JN2 · An Antidote for Dabigatran · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.